Repurposing Anti-Cancer Drugs for COVID-19 Treatment is a research paper published in Drug Design Development and Therapy (2020). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: T32 GM007337
NCI NIH HHS
Grant: F30 CA206255
National Institutes of Health
Grant: 5F30CA206255-02
The role of paracrine WNT5A/RYK in ErbB2-driven tumorigenesis
FWCI
0.70
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals